Concord Medical Services (NYSE: CCM ) announced today that it has closed the acquisition of 19.98% of indirect ownership of The University of Texas MD Anderson Cancer Center Proton Therapy Center (MD Anderson Proton Therapy Center). The company announced the signing of a definite agreement in connection with the acquisition